Shares of Ampio Pharmaceuticals (NYSEMKT: AMPE) were jumping 8.4% as of 11:51 a.m. EST on Thursday. The nice gain came after the company provided its fourth-quarter update following the market close on Wednesday.
Investors probably didn't care all that much about Ampio's Q4 results. (For what it's worth, the drugmaker posted a net loss of $15.9 million, or $0.09 per diluted share, with no revenue.) Instead, the primary catalyst for the biotech stock was that Ampio provided additional clarity on where it stands with the U.S. Food and Drug Administration (FDA) on a couple of fronts.
Image source: Getty Images.
For further details see:
Why Ampio Pharmaceuticals Stock Is Jumping Today